386
Participants
Start Date
March 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
SYR-472
SYR-472 3.125 mg, tablets, orally, once daily with lifestyle modification and/or metformin stable dose therapy for up to 12 weeks.
SYR-472
SYR-472 12.5 mg, tablets, orally, once daily with lifestyle modification and/or metformin stable dose therapy for up to 12 weeks.
SYR-472
SYR-472 50 mg, tablets, orally, once daily with lifestyle modification and/or metformin stable dose therapy for up to 12 weeks.
SYR-472
SYR-472 100 mg, tablets, orally, once daily with lifestyle modification and/or metformin stable dose therapy for up to 12 weeks.
Placebo
SYR-472 placebo-matching tablets, orally, once daily with lifestyle modification and/or metformin therapy for up to 12 weeks.
Sitagliptin
Sitagliptin 100 mg, tablets, orally, once daily with lifestyle modification and/or metformin stable dose therapy for up to 12 weeks.
Birmingham
Mobile
Montgomery
Phoenix
Tempe
Tucson
Anderson
Little Rock
Pine Bluff
Carmichael
Chino
Long Beach
Los Angeles
Los Gatos
Orange
Pico Rivera
Rolling Hills Estates
Roseville
Rowland Heights
Sacramento
Santa Ana
Stockton
Torrance
Arvada
Colorado Springs
Highlands Ranch
Avon
Rocky Hill
Newark
Aventura
Edgewater
Hollywood
Jacksonville
Kissimmee
Merritt Island
Miami
New Port Richey
Ocala
Pembroke Pines
Tampa
Zanesville
Atlanta
Roswell
Waycross
Idaho Falls
Chicago
Avon
Fort Wayne
Des Moines
Waterloo
Topeka
Wichita
Crestview
Oxon Hill
Detroit
Troy
Olive Branch
Kansas City
St Louis
Omaha
Las Vegas
West Caldwell
Wildwood Crest
Albuquerque
East Islip
Lewiston
New York
North Massapequa
Wantagh
Hickory
Statesville
Tabor City
Bismarck
Cincinnati
Columbus
Mason
Wadsworth
Norman
Oklahoma City
Tulsa
Eugene
Medford
Bensalem
Connellsville
Philadelphia
Pittsburgh
Shippensburg
Charleston
Greer
North Myrtle Beach
Chattanooga
Memphis
New Tazewell
Carrolton
Dallas
Georgetown
Houston
Killeen
San Antonio
Salt Lake City
Spanish Fork
Richmond
Suffolk
Virginia Beach
Spokane
Zapopan
Monterrey
Puebla City
Mexico City
Monterrey
Nezahualcóyotl
Veracruz
Lead Sponsor
Takeda
INDUSTRY